CBX3 and acute myeloid leukemia: The resulting heat map shows (Figure 8) that in addition to serous cystadenocarcinoma of the ovary (OV), acute myeloid leukemia (LAML), CESC, CHOL, testicular carcinoma (TGCT), uterine sarcoma (UCS), KICH, DLBC, KIRC, PAAD, the expression of CBX3 has a negative correlation with the immune score, stroma score and TME score in most tumors.